Botanical species · safety record
Physalis peruviana
The EFSA Compendium of Botanicals holds 26 constituent measurements and 3 adverse-effect records for Physalis peruviana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Physalis peruviana L.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- Withanolides9
- Tropane alkaloids3
- Physoperuvine2
- 1,8-cineole1
- 3alpha-tigloyloxytropane1
- Alkaloids1
- Benzaldehyde1
- Cardiac glycosides1
- Cuscohygrine1
- Hygrine1
Plant parts
- Fruit unspecified9
- Roots and other underground parts8
- Aerial part of plants7
- Leaves3
- Live plants1
- Unspecified1
Preparations
- Solvent extraction17
- Raw, no heat treatment6
- Powder2
Effect types
- Systemic2
- None1
Target tissues
- Urogenital: kidneys2
- Heart1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| 1,8-cineole | Fruit unspecified | — | 0.093 Microgram/100 gram | GC-MS | Resolve DOI |
| 3alpha-tigloyloxytropane | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Alkaloids | Fruit unspecified | Raw, no heat treatment | 1.31 Milligram/100 gram | Unspecified | Resolve DOI |
| Benzaldehyde | Fruit unspecified | — | 58.5 Microgram/100 gram | GC-MS | Resolve DOI |
| Cardiac glycosides | Fruit unspecified | Raw, no heat treatment | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Cuscohygrine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Hygrine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Myrcene | Fruit unspecified | — | 6.2 Microgram/100 gram | GC-MS | Resolve DOI |
| Phygrine | Aerial part of plants | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Physoperuvine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Saponins | Fruit unspecified | Raw, no heat treatment | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Steroidal saponins | Leaves | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Tropane alkaloids | Aerial part of plants | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Tropane alkaloids | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Tropane alkaloids | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Tropine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Withanolides | Aerial part of plants | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Withanolides | Unspecified | — | — | Unspecified | Resolve DOI |
| Withanolides | Aerial part of plants | Solvent extraction | 2.2 Milligram | Standard Chromatographic tests (paper- thin layer- and column chromatography) | Resolve DOI |
| Withanolides | Fruit unspecified | Raw, no heat treatment | 7.69 Milligram/100 gram | Unspecified | Resolve DOI |
| Withanolides | Aerial part of plants | Solvent extraction | 1.6 Milligram | Standard Chromatographic tests (paper- thin layer- and column chromatography) | Resolve DOI |
| Withanolides | Aerial part of plants | Solvent extraction | 2.9 Milligram | Standard Chromatographic tests (paper- thin layer- and column chromatography) | Resolve DOI |
| Withanolides | Aerial part of plants | Solvent extraction | 6.9 Milligram | Standard Chromatographic tests (paper- thin layer- and column chromatography) | Resolve DOI |
| Withanolides | Fruit unspecified | Raw, no heat treatment | 5.86 Milligram/100 gram | Unspecified | Resolve DOI |
| Physoperuvine | Roots and other underground parts | Solvent extraction | — | Unspecified | No resolvable identifier |
| Withanolides | Live plants | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| None | Urogenital: kidneys | Leaves | Powder | Guinea pig (as animal) | Acute toxicity | Resolve DOI |
| Systemic | Urogenital: kidneys | Leaves | Powder | Guinea pig (as animal) | Acute toxicity | Resolve DOI |
| Systemic | Heart | Fruit unspecified | Raw, no heat treatment | Rat (as animal) | Subchronic | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Xu, Ya-Ming., Wijeratne, E. M. Kithsiri., Babyak, Ashley L., Marks, Hanna R., Brooks, Alan D., Tewary, Poonam., Xuan, Li-Jiang., Wang, Wen-Qiong., Sayers, Thomas J., Gunatilaka, A. A. Leslie. Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells . Journal of natural products, 2017, vol. 80, no. 7, p. 1981-1991. DOI
- KUBWABO, C., ROLLMANN, B., TILQUIN, B. ANALYSIS OF ALKALOIDS FROM PHYSALIS-PERUVIANA BY CAPILLARY GC, CAPILLARY GC-MS, AND GC-FTIR . Planta medica, 1993, vol. 59, no. 2, p. 161-163. DOI
- Kasali, Felicien Mushagalusa., Kadima, Justin Ntokamunda., Mpiana, Pius Tshimankinda., Ngbolua, Koto-te-Nyiwa., Tshibangu, Damien Sha-Tshibey. Assessment of antidiabetic activity and acute toxicity of leaf extracts from Physalis peruviana L. in guinea-pig . Asian pacific journal of tropical biomedicine, 2013, vol. 3, no. 11, p. 841-846. DOI
- Ahmad, S., Yasmin, R., Malik, A. New withanolide glycosides from Physalis peruviana L.. Chemical & pharmaceutical bulletin, 1999, vol. 47, no. 4, p. 477-480.
- Lee, Chien-Chin., Chang, Wen-Hsin., Chang, Ya-Sian., Liu, Ting-Yuan., Chen, Yu-Chia., Wu, Yang-Chang., Chang, Jan-Gowth. 4 beta-Hydroxywithanolide E Modulates Alternative Splicing of Apoptotic Genes in Human Hepatocellular Carcinoma Huh-7 Cells . Scientific reports, 2017, vol. 7. DOI
- Henrich, C. J., Brooks, A. D., Erickson, K. L., Thomas, C. L., Bokesch, H. R., Tewary, P., Thompson, C. R., Pompei, R. J., Gustafson, K. R., McMahon, J. B., Sayers, T. J. Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation . Cell death & disease, 2015, vol. 6. DOI
- El-Gengaihi, Souad E., Hamed, Manal A., Khalaf-Allah, Abd El-Rahman M., Mohammed, Mona A. Golden Berry Juice Attenuates the Severity of Hepatorenal Injury. Journal of dietary supplements, 2013, vol. 10, no. 4, p. 357-369. DOI
- Perk, Basak Ozlem., Ilgin, Sinem., Atli, Ozlem., Duymus, Hale Gamze., Sirmagul, Basar. Acute and Subchronic Toxic Effects of the Fruits of Physalis peruviana L. . Evidence-based complementary and alternative medicine, 2013. DOI
- BASEY, K., MCGAW, BA., WOOLLEY, JG. PHYGRINE, AN ALKALOID FROM PHYSALIS SPECIES. Phytochemistry, 1992, vol. 31, no. 12, p. 4173-4176. DOI
- Arun, M., Asha, V. V. Preliminary studies on antihepatotoxic effect of Physalis peruviana Linn. (Solanaceae) against carbon tetrachloride induced acute liver injury in rats . Journal of ethnopharmacology, 2007, vol. 111, no. 1, p. 110-114. DOI
- Ray, Anil B., Sahai, Mahendra., Sethi, Prabhu D. Physoperuvine, a new alkaloid of Physalis peruviana Linn. Chemistry & industry (london, united kingdom), 1976, vol. (10), p. 454-5.
- Kupska, Magdalena., Jelen, Henryk H. In-tube extraction for the determination of the main volatile compounds in Physalis peruviana L . Journal of separation science, 2017, vol. 40, no. 2, p. 532-541. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.